Disease- and sex-specific differences in patients with heart valve disease: a proteome study.
Sarah NordmeyerMilena KrausMatthias ZiehmMarieluise KirchnerMarie SchafsteddeMarcus KelmSylvia NiquetMariet Mathew StephenIstvan BaczkoChristoph KnosallaMatthieu-P SchapranowGunnar DittmarMichael GotthardtMartin FalckeVera Regitz-ZagrosekTitus KuehnePhilipp MertinsPublished in: Life science alliance (2023)
Pressure overload in patients with aortic valve stenosis and volume overload in mitral valve regurgitation trigger specific forms of cardiac remodeling; however, little is known about similarities and differences in myocardial proteome regulation. We performed proteome profiling of 75 human left ventricular myocardial biopsies (aortic stenosis = 41, mitral regurgitation = 17, and controls = 17) using high-resolution tandem mass spectrometry next to clinical and hemodynamic parameter acquisition. In patients of both disease groups, proteins related to ECM and cytoskeleton were more abundant, whereas those related to energy metabolism and proteostasis were less abundant compared with controls. In addition, disease group-specific and sex-specific differences have been observed. Male patients with aortic stenosis showed more proteins related to fibrosis and less to energy metabolism, whereas female patients showed strong reduction in proteostasis-related proteins. Clinical imaging was in line with proteomic findings, showing elevation of fibrosis in both patient groups and sex differences. Disease- and sex-specific proteomic profiles provide insight into cardiac remodeling in patients with heart valve disease and might help improve the understanding of molecular mechanisms and the development of individualized treatment strategies.
Keyphrases
- aortic stenosis
- aortic valve
- ejection fraction
- left ventricular
- transcatheter aortic valve replacement
- aortic valve replacement
- mitral valve
- transcatheter aortic valve implantation
- high resolution
- heart failure
- hypertrophic cardiomyopathy
- acute myocardial infarction
- end stage renal disease
- tandem mass spectrometry
- coronary artery disease
- left atrial
- newly diagnosed
- cardiac resynchronization therapy
- mass spectrometry
- chronic kidney disease
- case report
- patient reported outcomes
- drug induced
- photodynamic therapy
- liquid chromatography
- ms ms
- high speed